Research output per year
Research output per year
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant
Holthof, L. C., Stikvoort, A., van der Horst, H. J., Gelderloos, A. T., Poels, R., Li, F., Groen, R. W. J., Zweegman, S., van de Donk, N. W. C. J., O'Dwyer, M. & Mutis, T., May 2021, In: HemaSphere. 5, 5, p. e561Research output: Contribution to journal › Article › Academic › peer-review
-
Bone Marrow Mesenchymal Stromal Cells can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis
Holthof, L. C., van der Schans, J. J., Katsarou, A., Poels, R., Gelderloos, A. T., Drent, E., van Hal-van Veen, S. E., Li, F., Zweegman, S., van de Donk, N. W. C. J., Themeli, M., Groen, R. W. & Mutis, T., 21 Apr 2021, In: Clinical cancer research : an official journal of the American Association for Cancer Research.Research output: Contribution to journal › Article › Academic › peer-review
-
Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab
Casneuf, T., Adams, H. C., van de Donk, N. W. C. J., Abraham, Y., Bald, J., Vanhoof, G., Van der Borght, K., Smets, T., Foulk, B., Nielsen, K. C., Rusbuldt, J., Axel, A., Lysaght, A., Ceulemans, H., Stevenaert, F., Usmani, S. Z., Plesner, T., Avet-Loiseau, H., Nijhof, I., Mutis, T. & 3 others, , Feb 2021, In: Leukemia. 35, 2, p. 573-584 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment
van der Horst, H. J., de Jonge, A. V., Hiemstra, I. H., Gelderloos, A. T., Berry, D. R. A. I., Hijmering, N. J., van Essen, H. F., de Jong, D., Chamuleau, M. E. D., Zweegman, S., Breij, E. C. W., Roemer, M. G. M. & Mutis, T., 1 Feb 2021, In: Blood cancer journal. 11, 2, 38.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Preclinical evaluation of invariant natural killer t cells modified with cd38 or bcma chimeric antigen receptors for multiple myeloma
Poels, R., Drent, E., Lameris, R., Katsarou, A., Themeli, M., van der Vliet, H. J., de Gruijl, T. D., van de Donk, N. W. C. J. & Mutis, T., 1 Feb 2021, In: International Journal of Molecular Sciences. 22, 3, p. 1-16 16 p., 1096.Research output: Contribution to journal › Article › Academic › peer-review
Open Access